| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 8.85% |
| Cipla Ltd. | Healthcare | Equity | 8.63% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 7.76% |
| Globus Medical Inc | Healthcare | Forgn. Eq | 6.89% |
| Laurus Labs Ltd. | Healthcare | Equity | 6.21% |
| Illumina Inc. (USA) | Healthcare | Forgn. Eq | 5.93% |
| Cohance Lifesciences Ltd. | Healthcare | Equity | 5.27% |
| Gland Pharma Ltd. | Healthcare | Equity | 5.10% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 4.99% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 4.49% |
| Alembic Pharmaceuticals Ltd. | Healthcare | Equity | 4.08% |
| Pfizer Ltd. | Healthcare | Equity | 3.14% |
| Kovai Medical Center & Hospital Ltd. | Healthcare | Equity | 3.12% |
| Intuitive Surgical Inc. (USA) | Healthcare | Forgn. Eq | 3.03% |
| Vijaya Diagnostic Centre Ltd. | Healthcare | Equity | 2.94% |
| Procter & Gamble Health Ltd. | Healthcare | Equity | 2.87% |
| Indoco Remedies Ltd. | Healthcare | Equity | 2.61% |
| Concord Biotech Ltd. | Healthcare | Equity | 2.18% |
| Emcure Pharmaceuticals Ltd. | Healthcare | Equity | 1.73% |
| ICICI Lombard General Insurance Company Ltd. | Insurance | Equity | 1.50% |
| Unichem Laboratories Ltd. | Healthcare | Equity | 1.25% |
| Abbott Laboratories | Healthcare | Forgn. Eq | 1.15% |
| Aarti Drugs Ltd. | Healthcare | Equity | 1.14% |
| Global X Genomics & Biotechnology ETF | Financial | Foreign MF | 0.80% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 0.67% |
| Medplus Health Services Ltd. | Healthcare | Equity | 0.49% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | Equity | 0.44% |
| Grail Inc | Healthcare | Forgn. Eq | 0.27% |
| Laxmi Dental Ltd. | Healthcare | Equity | 0.24% |
| Thyrocare Technologies Ltd. | Healthcare | Equity | 0.12% |
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | -5.9% | +21.3% | +14.8% | +21.3% |
| Category average (Equity Sectoral) | -2.1% | +22.1% | +14.6% | -- |
| Rank (Equity Sectoral) | 25 | 13 | 3 | -- |